Drug & Cancer & Variant
Result
Search content: Gene = ABCB1
There are 3 entries with your keyword(s).
Gene Variant Type Tumor Drug Drug level Reference More
ABCB1 I1145I MUT Non-Small Cell Lung Cancer Carboplatin II 1
Evidence region

CIVIC

Patient Criteria

-

Note

The mutation at codon 3435 (C>T) correlated with a significantly higher response rate to platinum-based chemotherapy in patients with advanced non small cell lung cancer (NSCLC). 103 Chinese patients with NSCLC were evaluated in this study. However, there was not a significant correlation between the mutation and overall survival.

Gene name

ABCB1

Full name

ATP binding cassette subfamily B member 1

Gene type

protein-coding

Function

The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017]

Drug name

Carboplatin

DrugBank ID

DB00958

Synonyms

Carboplatin
Carboplatine
Carboplatino
CBDCA
cis-(1,1-cyclobutanedicarboxylato)diammineplatinum(II)
cis-diammine(1,1-cyclobutanedicarboxylato)platinum
cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II)

Brand

Paraplatin Inj 150mg/vial
Carboplatin Injection BP
Paraplatin
Carboplatin Injection Liq 10mg/ml
Carboplatin Injection, BP
Paraplatin-AQ Inj 10mg/ml
Carboplatin
CARBOplatin
Carboplatin Injection

Description

An organoplatinum compound that possesses antineoplastic activity.

Target gene

-

ABCB1 I1145I MUT Non-Small Cell Lung Cancer Cisplatin II 1
Evidence region

CIVIC

Patient Criteria

-

Note

The mutation at codon 3435 (C>T) correlated with a significantly higher response rate to platinum-based chemotherapy in patients with advanced non small cell lung cancer (NSCLC). 103 Chinese patients with NSCLC were evaluated in this study. However, there was not a significant correlation between the mutation and overall survival.

Gene name

ABCB1

Full name

ATP binding cassette subfamily B member 1

Gene type

protein-coding

Function

The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017]

Drug name

Cisplatin

DrugBank ID

DB00515

Synonyms

CDDP
Cis-DDP
cis-diamminedichloroplatinum(II)
Cisplatin
cisplatino

Brand

Cisplatin Injection, Mylan Std.
Cisplatin Injection, BP
Cisplatin Injection BP
Cisplatin
Cisplatin Inj 0.5mg/ml
Platinol-AQ
PMS-cisplatin
Cisplatin Injection
Cisplatin Inj 1mg/ml
Platinol AQ Inj 1mg/ml
Platinol
CISplatin

Description

Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.

Target gene
GeneFunction
MPGUnknown
A2MUnknown
TFUnknown
ATOX1Unknown
ABCB1 S829T MUT Ovarian Cancer Paclitaxel II 1
Evidence region

CIVIC

Patient Criteria

-

Note

The ABCB1 G2677T/A (S893T, rs2032582) homozygous variant was positively correlated with response to paclitaxel treatment in ovarian cancer patients. 51 epithelial and 2 fallopian tube frozen tumors were analyzed for this study.

Gene name

ABCB1

Full name

ATP binding cassette subfamily B member 1

Gene type

protein-coding

Function

The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017]

Drug name

Paclitaxel

DrugBank ID

DB01229

Synonyms

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
Paclitaxel
Taxol A

Brand

Taxol
Paclitaxel Injection
Paclitaxel Injection USP
Paxene
Aj-paclitaxel
Abraxane
Paclitaxel NP
Apealea
Teva-paclitaxel for Injection
Paclitaxel for Injection
Paclitaxel for Injection USP
Abraxane for Injectable Suspension
Apo-paclitaxel Injectable
Onxol
Paclitaxel Paclitaxel
Paclitaxel Injection, USP
Paclitaxel

Description

Paclitaxel is a chemotherapeutic agent marketed under the brand name Taxol among others. Used as a treatment for various cancers, paclitaxel is a mitotic inhibitor that was first isolated in 1971 from the bark of the Pacific yew tree which contains endophytic fungi that synthesize paclitaxel. It is available as an intravenous solution for injection and the newer formulation contains albumin-bound paclitaxel marketed under the brand name Abraxane.

Target gene
GeneFunction
TUBB1inhibitor
BCL2inhibitor
MAP4Unknown
MAP2Unknown
MAPTUnknown
NR1I2inducer
Showing 1 to 3 of 3 entries, entries per page